Crinetics Pharmaceuticals Competitors and Similar CompaniesClear all
Crinetics Pharmaceuticals's competitors and similar companies include Immatics.
 Crinetics Pharmaceuticals Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors. |  Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US |
Employees | Employees 43751% increase | Employees 29723% increase |
Valuation ($) | Valuation ($) 5.1 b | Valuation ($) 1.1 b |
Financial | ||
Revenue (est.) | Revenue (est.) $7.7m (FY, 2025) | Revenue (est.) €48.3m (FY, 2025) |
Cost of goods | Cost of goods $1.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $6.6m (FY, 2025) | Gross profit €53m (FY, 2025) |
Net income | Net income ($465.3m) (FY, 2025) | Net income (€196.4m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 41.5m | Total funding raised $ 267.3m |
For sources of this data, please see the company profile
View Company Profiles
Immatics
HQ
Tübingen, DE
Employees
297↑ 23% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View company